India, April 24 -- The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, has signed two key Memoranda of Understanding (MoUs) with the Pharmaceuticals and Medical Devices Bureau of India and National Institute of Pharmaceutical Education and Research Hajipur to strengthen drug quality, research, and patient safety in India.
The MoU with PMBI focuses on enhancing quality assurance of medicines distributed through Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs). Under this collaboration, randomly selected batches of Jan Aushadhi medicines may be tested by IPC to ensure quality standards. The partnership will also promote the use of the National Formulary of India (NFI) for rational drug usage and st...